Simplex Trading »

Entrada Therapeutics shares owned by Simplex Trading

Quarter-by-quarter ownership of Entrada Therapeutics (TRDA) shares owned by Simplex Trading from 13F filings

Historical chart of Simplex Trading investment in Entrada Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Entrada Therapeutics held by Simplex Trading consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Entrada Therapeutics by Simplex Trading

Quarter filed Position value Share count Share price at filing
2024-09-30 $16k 1.0k 15.73

More positions owned by Simplex Trading

Spdr S&p 500 Etf Tr Put Put Option
Spdr S&p 500 Etf Tr Call Call Option
Tesla Call Call Option
Tesla Put Put Option
Invesco Qqq Tr Put Put Option
Nvidia Corporation Call Call Option
Nvidia Corporation Put Put Option
Ishares Tr Put Put Option
Apple Call Call Option
Apple Put Put Option
Ishares Tr Call Call Option
Invesco Qqq Tr Call Call Option
Meta Platforms Call Call Option
Select Sector Spdr Tr Put Put Option
Microsoft Corp Call Call Option

View all positions for Simplex Trading

Top funds holding Entrada Therapeutics

Baker Bros. Advisors
5AM Venture Management
MPM Asset Management
T. Rowe Price Associates
Henderson Group
BlackRock
Vanguard Group
FMR
Wellington Management Company
StepStone
TCG Crossover Management
Geode Capital Management
State Street Corporation
Northern Trust
Goldman Sachs Group

View all funds holding Entrada Therapeutics